Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 28

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 28, 2014; 20(28): 9427-9438
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9427

Table 3 Factors implicated in inducing bone loss in liver disease

Fibronectin (plasma and oncofetal forms)

IGF-I

RANKL/OPG

IL-6

Sex hormones

Bilirubin

Vitamin D metabolism

Corticosteroid therapy

IGF-I: Insulin like growth factor-I; IL: Interleukin; OPG: Osteoprotegerin; RANKL: Receptor-activator of nuclear factor kappa ligand.

Citation: Nakchbandi IA. Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications. World J Gastroenterol 2014; 20(28): 9427-9438
URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9427.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9427

Nakchbandi IA. Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications. World J Gastroenterol 2014; 20(28): 9427-9438 [PMID: 25071337 DOI: 10.3748/wjg.v20.i28.9427]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.